Ultragenyx Pharmaceutical Inc. Files 8-K
Ticker: RARE · Form: 8-K · Filed: Jul 11, 2025 · CIK: 1515673
| Field | Detail |
|---|---|
| Company | Ultragenyx Pharmaceutical Inc. (RARE) |
| Form Type | 8-K |
| Filed Date | Jul 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
Related Tickers: UGNX
TL;DR
UGNX filed an 8-K, but no details yet on what happened.
AI Summary
Ultragenyx Pharmaceutical Inc. filed an 8-K on July 11, 2025, to report other events. The filing does not contain specific details about the nature of these events, dollar amounts, or definitive dates beyond the filing date itself.
Why It Matters
This filing indicates Ultragenyx Pharmaceutical Inc. has reported an event to the SEC, but the lack of specific details means investors cannot yet assess its impact.
Risk Assessment
Risk Level: low — The filing is a standard procedural document with no immediate disclosed financial or operational impact.
Key Players & Entities
- Ultragenyx Pharmaceutical Inc. (company) — Registrant
- July 11, 2025 (date) — Filing Date
FAQ
What specific event is Ultragenyx Pharmaceutical Inc. reporting in this 8-K filing?
The filing does not specify the nature of the 'Other Events' being reported.
When was this 8-K filing submitted to the SEC?
The filing was submitted on July 11, 2025.
What is the principal executive office address for Ultragenyx Pharmaceutical Inc.?
The address is 60 Leveroni Court, Novato, California, 94949.
What is the IRS Employer Identification Number for Ultragenyx Pharmaceutical Inc.?
The IRS EIN is 27-2546083.
Under which section of the Securities Exchange Act is this report filed?
This is a Current Report filed Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 11, 2025 regarding Ultragenyx Pharmaceutical Inc. (RARE).